MCH ADVISORY RESEARCH
Sector

Materials

51 companies under coverage across 13 industries.

Industries

Browse by industry


Coverage

Materials companies


Equity Research

Westlake Chemical Corporation (WLK)

HOLD. 12-month probability-weighted target $78 (+2% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

WLKEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Vulcan Materials Company (VMC)

HOLD. 12-month probability-weighted target $308 (+12% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

VMCEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Smurfit WestRock plc (SW)

HOLD. 12-month probability-weighted target $45 (-8% vs spot). Gross Margin explains 86% of Monte Carlo outcome variance.

SWEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Steel Dynamics Inc (STLD)

HOLD. 12-month probability-weighted target $260 (+14% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

STLDEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Sonoco Products Company (SON)

HOLD. 12-month probability-weighted target $54 (-6% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SONEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Solstice Advanced Materials, Inc (SOLS)

HOLD. 12-month probability-weighted target $57 (+3% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

SOLSEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Scotts Miracle-Gro Company (SMG)

HOLD. 12-month probability-weighted target $68 (+13% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

SMGEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Silgan Holdings Inc (SLGN)

HOLD. 12-month probability-weighted target $45 (+5% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SLGNEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Sherwin-Williams Co (SHW)

HOLD. 12-month probability-weighted target $336 (-3% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

SHWEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Reliance Steel & Aluminum Co (RS)

SELL. 12-month probability-weighted target $312 (-18% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

RSEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

RPM International Inc (RPM)

HOLD. 12-month probability-weighted target $103 (-3% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

RPMEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Royal Gold Inc (RGLD)

HOLD. 12-month probability-weighted target $318 (+20% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

RGLDEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

PPG Industries Inc (PPG)

HOLD. 12-month probability-weighted target $118 (+4% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PPGEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Packaging Corp of America (PKG)

HOLD. 12-month probability-weighted target $244 (-2% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PKGEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Olin Corporation (OLN)

BUY. 12-month probability-weighted target $24 (+37% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

OLNEquity ResearchMonte Carlo
25 August 2026Rating: BUY
Equity Research

Nucor Corp (NUE)

HOLD. 12-month probability-weighted target $256 (+4% vs spot). P/E Multiple explains 46% of Monte Carlo outcome variance.

NUEEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

NewMarket Corporation (NEU)

SELL. 12-month probability-weighted target $796 (-15% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

NEUEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Newmont Corporation (NEM)

SELL. 12-month probability-weighted target $106 (-20% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

NEMEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

The Mosaic Company (MOS)

SELL. 12-month probability-weighted target $18 (-24% vs spot). Gross Margin explains 85% of Monte Carlo outcome variance.

MOSEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Martin Marietta Materials Inc (MLM)

HOLD. 12-month probability-weighted target $616 (+16% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

MLMEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

LyondellBasell Industries NV (LYB)

SELL. 12-month probability-weighted target $58 (-10% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

LYBEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Linde plc Ordinary Shares (LIN)

HOLD. 12-month probability-weighted target $523 (+7% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

LINEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Knife River Corporation (KNF)

HOLD. 12-month probability-weighted target $79 (+24% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

KNFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

International Paper (IP)

SELL. 12-month probability-weighted target $35 (-14% vs spot). Gross Margin explains 88% of Monte Carlo outcome variance.

IPEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

International Flavors & Fragrances Inc (IFF)

SELL. 12-month probability-weighted target $75 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

IFFEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Hecla Mining Company (HL)

SELL. 12-month probability-weighted target $14 (-31% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

HLEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Graphic Packaging Holding Company (GPK)

HOLD. 12-month probability-weighted target $11 (-5% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

GPKEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Greif Bros Corporation (GEF)

HOLD. 12-month probability-weighted target $81 (-6% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

GEFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Freeport-McMoran Copper & Gold Inc (FCX)

SELL. 12-month probability-weighted target $66 (-16% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

FCXEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Eagle Materials Inc (EXP)

HOLD. 12-month probability-weighted target $206 (+1% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

EXPEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Ecolab Inc (ECL)

HOLD. 12-month probability-weighted target $277 (-3% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ECLEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Dow Inc (DOW)

HOLD. 12-month probability-weighted target $29 (-8% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

DOWEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Dupont De Nemours Inc (DD)

HOLD. 12-month probability-weighted target $135 (-1% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

DDEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Corteva Inc (CTVA)

HOLD. 12-month probability-weighted target $79 (-4% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

CTVAEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

CRH PLC ADR (CRH)

HOLD. 12-month probability-weighted target $113 (+18% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

CRHEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Commercial Metals Company (CMC)

HOLD. 12-month probability-weighted target $67 (+3% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

CMCEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Cleveland-Cliffs Inc (CLF)

HOLD. 12-month probability-weighted target $10 (-11% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

CLFEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

CF Industries Holdings Inc (CF)

SELL. 12-month probability-weighted target $72 (-44% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

CFEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Coeur Mining Inc (CDE)

SELL. 12-month probability-weighted target $16 (-21% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

CDEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Crown Holdings Inc (CCK)

HOLD. 12-month probability-weighted target $116 (-3% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

CCKEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Cabot Corporation (CBT)

HOLD. 12-month probability-weighted target $92 (+10% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

CBTEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Ball Corporation (BALL)

HOLD. 12-month probability-weighted target $60 (-7% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BALLEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Axalta Coating Systems Ltd (AXTA)

HOLD. 12-month probability-weighted target $36 (+1% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AXTAEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Avery Dennison Corp (AVY)

HOLD. 12-month probability-weighted target $162 (-12% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

AVYEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Avient Corp (AVNT)

HOLD. 12-month probability-weighted target $42 (-5% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

AVNTEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

AptarGroup Inc (ATR)

HOLD. 12-month probability-weighted target $128 (-5% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

ATREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Ashland Global Holdings Inc (ASH)

SELL. 12-month probability-weighted target $63 (-14% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ASHEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Air Products and Chemicals Inc (APD)

HOLD. 12-month probability-weighted target $284 (-7% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

APDEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Amcor PLC (AMCR)

SELL. 12-month probability-weighted target $41 (-14% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

AMCREquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Albemarle Corp (ALB)

HOLD. 12-month probability-weighted target $141 (-1% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Alcoa Corp (AA)

HOLD. 12-month probability-weighted target $49 (+0% vs spot). P/E Multiple explains 47% of Monte Carlo outcome variance.

AAEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English